| Group I | Group II | X2 | P |
Inflammatory signs: |
|
|
|
|
Preprocedure | 18 (90%) | 18 (90%) | 0.44 | 0.83 |
During procedure |
|
|
|
|
1st month | 12 (60%) | 16 (80%) | 3.73 | 0.15 |
2nd month | 6 (30%) | 9 (45%) | 1.78 | 0.41 |
3rd month | 2 (10%) | 2 (10%) | 5.57 | 0.06* |
Infective signs: |
|
|
|
|
Preprocedure | 15 (75%) | 14 (70%) | 0.48 | 0.49 |
During procedure |
|
|
|
|
1st month | 11 (55%) | 10 (50%) | 0.82 | 0.49 |
2nd month | 6 (30%) | 4 (20%) | 0.50 | 1.37 |
3rd month | 2 (10%) | 1 (5%) | 0.77 | 0.54 |
Decrease of pain: |
|
|
|
|
1st month | 11 (55%) | 15 (75%) | 3.33 | 0.19 |
2nd month | 5 (25%) | 8 (40%) | 6.85 | 0.04* |
3rd month | 1 (5%) | 1 (5%) | 9.41 | 0.07* |
Recurrence: |
|
|
|
|
3 months follow up | 2 (10%) | 1 (5%) | 2.26 | 0.32 |
6 months follow up | 3 (15%) | 2 (10%) | 0.32 | 0.85 |
9 months follow up | 2 (10%) | 2 (10%) | 0.32 | 0.85 |
Total No. | 7 (35%) | 5 (25%) | 1.76 | 0.42 |